Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL44 (11-isosparteine, 4',5,7-trihydroxyisoflavone, .alpha.-isospartein, (-)-.alpha.-isosparteine, .alpha.-isosparteine, .alpha.-isosparteine, (-)-, .alpha.-sparteine, BIO 300, BIO-300, Bonistein, FW-635I-2, Genistein, Genisteine-alkaloid, Isosparteine, alpha-, NPI-031L, NSC-36586, NSC-366737, SIPI-807-1, Sophoricol, Sparteine l-.alpha.-isosparteine) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
A1 receptor/Adenosine A1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542] | ||||||||
ChEMBL | DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) | B | 4.94 | pKi | 11611 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) | B | 4.7 | pIC50 | 19904 | nM | IC50 | DrugMatrix in vitro pharmacology data |
A1 receptor/Adenosine A1 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL318] [GtoPdb: 18] [UniProtKB: P25099] | ||||||||
ChEMBL | Tested for the displacement [3H]PIA from Adenosine A1 receptor in rat brain membrane | B | 5.3 | pKi | 5000 | nM | Ki | J Med Chem (1996) 39: 398-406 [PMID:8558508] |
ChEMBL | Displacement of specific [3H]PIA binding from adenosine A1 receptor in rat brain membranes. | B | 5.3 | pKi | 5000 | nM | Ki | J Med Chem (1996) 39: 781-788 [PMID:8576921] |
A2A receptor/Adenosine A2a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL251] [GtoPdb: 19] [UniProtKB: P29274] | ||||||||
ChEMBL | DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) | B | 5.01 | pKi | 9792 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) | B | 4.76 | pIC50 | 17442 | nM | IC50 | DrugMatrix in vitro pharmacology data |
A2A receptor/Adenosine A2a receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL302] [GtoPdb: 19] [UniProtKB: P30543] | ||||||||
ChEMBL | Displacement [3H]-CGS-21,680 from Adenosine A2A receptor in rat striatal membrane. | B | 4.44 | pKi | 36000 | nM | Ki | J Med Chem (1996) 39: 398-406 [PMID:8558508] |
ChEMBL | Affinity at Adenosine A2A receptor in rat striatal membranes by [3H]- CGS 21680 displacement. | B | 4.44 | pKi | 36000 | nM | Ki | J Med Chem (1996) 39: 781-788 [PMID:8576921] |
aldo-keto reductase family 1 member B/Aldose reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1900] [GtoPdb: 2768] [UniProtKB: P15121] | ||||||||
ChEMBL | Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry | B | 4.7 | pIC50 | 20000 | nM | IC50 | Bioorg Med Chem (2012) 20: 1251-1258 [PMID:22261024] |
aldo-keto reductase family 1 member B/Aldose reductase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2622] [GtoPdb: 2768] [UniProtKB: P07943] | ||||||||
ChEMBL | DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) | B | 4.35 | pIC50 | 44979 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Alpha-glucosidase MAL62 in Saccharomyces cerevisiae (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4357] [UniProtKB: P07265] | ||||||||
ChEMBL | Inhibition of baker's yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate by spectrophotometry | B | 0.84 | pIC50 | 0.84 | - | logIC50 | Med Chem Res (2012) 21: 3984-3993 |
Alpha-L-fucosidase 1 in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3545] [UniProtKB: Q2KIM0] | ||||||||
ChEMBL | Inhibition of bovine kidney alpha-fucosidase using PNPG as substrate incubated for 10 mins by spectrophotometric method | B | 4.27 | pIC50 | 54000 | nM | IC50 | Eur J Med Chem (2020) 188: 112034-112034 [PMID:31927314] |
Alpha-mannosidase in Canavalia ensiformis (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3392945] [UniProtKB: C0HJB3] | ||||||||
ChEMBL | Inhibition of jack bean alpha-mannosidase using PNPG as substrate incubated for 10 mins by spectrophotometric method | B | 4.31 | pIC50 | 49000 | nM | IC50 | Eur J Med Chem (2020) 188: 112034-112034 [PMID:31927314] |
Androgen receptor/Androgen Receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3072] [GtoPdb: 628] [UniProtKB: P15207] | ||||||||
ChEMBL | Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881) | B | 4.07 | pIC50 | 85113.8 | nM | IC50 | J Med Chem (2005) 48: 5666-5674 [PMID:16134935] |
Arachidonate 15-lipoxygenase in Rabbit (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4358] [UniProtKB: P12530] | ||||||||
ChEMBL | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | B | 5.04 | pIC50 | 9033 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ABCG2/ATP-binding cassette sub-family G member 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5393] [GtoPdb: 792] [UniProtKB: Q9UNQ0] | ||||||||
ChEMBL | Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining | B | 5.06 | pIC50 | 8800 | nM | IC50 | Bioorg Med Chem (2011) 19: 2090-2102 [PMID:21354800] |
ChEMBL | Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining | B | 5.16 | pIC50 | 6900 | nM | IC50 | Bioorg Med Chem (2011) 19: 2090-2102 [PMID:21354800] |
Cruzipain in Trypanosoma cruzi (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3563] [UniProtKB: P25779] | ||||||||
ChEMBL | Inhibition of Trypanosoma cruzi cruzaine using Z-Phe-Arg-aminomethylcoumarin as substrate incubated for 5 mins by spectrofluorimetric analysis in absence of Tween-80 | B | 4.08 | pIC50 | 82700 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
ChEMBL | Inhibition of COX1 | B | 4.1 | pIC50 | 80000 | nM | IC50 | J Nat Prod (2005) 68: 985-991 [PMID:16038536] |
CFTR/Cystic fibrosis transmembrane conductance regulator in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4051] [GtoPdb: 707] [UniProtKB: P13569] | ||||||||
ChEMBL | Potentiation of wild-type CFTR (unknown origin) expressed in FRT cells assessed as chloride transport by measuring membrane potential in presence of forskolin | B | 4.85 | pEC50 | 14200 | nM | EC50 | J Med Chem (2021) 64: 7241-7260 [PMID:34028270] |
ChEMBL | Potentiation of CFTR F508del mutant (unknown origin) expressed in CHO cells assessed as chloride transport by measuring membrane potential incubated for 5 to 30 mins in presence of forskolin by Quattro assay | B | 5.07 | pEC50 | 8480 | nM | EC50 | J Med Chem (2021) 64: 7241-7260 [PMID:34028270] |
ChEMBL | Potentiation of CFTR F508del mutant (unknown origin) expressed in CHO cells assessed as chloride transport by measuring membrane potential preincubated for 5 mins followed by forskolin addition by FLIPR assay | B | 5.09 | pEC50 | 8200 | nM | EC50 | J Med Chem (2021) 64: 7241-7260 [PMID:34028270] |
ChEMBL | Potentiation of CFTR F508del mutant (unknown origin) expressed in FRT cells assessed as chloride transport by measuring membrane potential in presence of forskolin | B | 5.21 | pEC50 | 6170 | nM | EC50 | J Med Chem (2021) 64: 7241-7260 [PMID:34028270] |
CFTR/Cystic fibrosis transmembrane conductance regulator in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3992] [GtoPdb: 707] [UniProtKB: P34158] | ||||||||
ChEMBL | Kd (half effective concentration) of compound against CFTR (cystic fibrosis transmembrane conductance regulator) in rat was determined | B | 4.4 | pKd | 40000 | nM | Kd | Bioorg Med Chem Lett (2003) 13: 2509-2512 [PMID:12852954] |
CYP19A1/Cytochrome P450 19A1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1978] [GtoPdb: 1362] [UniProtKB: P11511] | ||||||||
ChEMBL | Inhibition of human aromatase expressed in CHO cells | B | 4 | pKi | 100000 | nM | Ki | Bioorg Med Chem (2008) 16: 8466-8470 [PMID:18778944] |
death associated protein kinase 1/Death-associated protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2558] [GtoPdb: 2002] [UniProtKB: P53355] | ||||||||
ChEMBL | Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay | B | 4.01 | pIC50 | 98000 | nM | IC50 | J Med Chem (2015) 58: 7400-7408 [PMID:26322379] |
dipeptidyl peptidase 4/Dipeptidyl peptidase IV in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL284] [GtoPdb: 1612] [UniProtKB: P27487] | ||||||||
ChEMBL | Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay | B | 6.32 | pIC50 | 480 | nM | IC50 | Eur J Med Chem (2018) 151: 145-157 [PMID:29609120] |
DNA methyltransferase 1/DNA (cytosine-5)-methyltransferase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1993] [GtoPdb: 2605] [UniProtKB: P26358] | ||||||||
ChEMBL | Inhibition of His6-tagged human recombinant DNMT1 expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintillation counting method | B | 4.52 | pIC50 | 30000 | nM | IC50 | J Med Chem (2015) 58: 2569-2583 [PMID:25406944] |
DNA (cytosine-5-)-methyltransferase 3α/DNMT3A2/3L complex in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3137291] [GtoPdb: 2750] [UniProtKB: Q9UJW3, Q9Y6K1] | ||||||||
ChEMBL | Inhibition of His6-tagged human recombinant DNMT3A/DNMT3L expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintillation counting method | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2015) 58: 2569-2583 [PMID:25406944] |
DAT/Dopamine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL238] [GtoPdb: 927] [UniProtKB: Q01959] | ||||||||
ChEMBL | DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 4.87 | pKi | 13442 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 4.77 | pIC50 | 16918 | nM | IC50 | DrugMatrix in vitro pharmacology data |
mitogen-activated protein kinase kinase 4/Dual specificity mitogen-activated protein kinase kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2897] [GtoPdb: 2065] [UniProtKB: P45985] | ||||||||
ChEMBL | Inhibition of recombinant human MEK4 (14 to 377 residues) after 5 mins by Western blot analysis | B | 6.4 | pIC50 | 400 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127203-127203 [PMID:32389527] |
epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
ChEMBL | Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay | B | 4.6 | pIC50 | 25120 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 4659-4663 [PMID:25205190] |
ChEMBL | Inhibition of wild type EGFR | B | 5.59 | pIC50 | 2600 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
ChEMBL | Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD) | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (1994) 37: 1015-1027 [PMID:8151612] |
ChEMBL | Inhibition of Epidermal growth factor receptor | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (1999) 42: 1018-1026 [PMID:10090785] |
ChEMBL | In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (1995) 38: 2441-2448 [PMID:7608909] |
Estradiol 17-beta-dehydrogenase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3181] [UniProtKB: P14061] | ||||||||
ChEMBL | Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol | B | 5.66 | pIC50 | 2210 | nM | IC50 | J Med Chem (2008) 51: 4188-4199 [PMID:18533708] |
hydroxysteroid 17-beta dehydrogenase 2/Estradiol 17-beta-dehydrogenase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2789] [GtoPdb: 3094] [UniProtKB: P37059] | ||||||||
ChEMBL | Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol | B | 4.78 | pIC50 | 16500 | nM | IC50 | J Med Chem (2008) 51: 4188-4199 [PMID:18533708] |
ChEMBL | Inhibition of human 17beta-HSD2 expressed in HEK293 cell lysates incubated for 10 mins using [2,4,6,7-3H]-estradiol and NAD+ by scintillation counting method | B | 4.78 | pIC50 | 16500 | nM | IC50 | J Nat Prod (2017) 80: 965-974 [PMID:28319389] |
Estrogen receptor-α/Estrogen receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL206] [GtoPdb: 620] [UniProtKB: P03372] | ||||||||
ChEMBL | Inhibition of binding of 17 beta-estradiol to human Estrogen receptor alpha | B | 6.43 | pKi | 370 | nM | Ki | Bioorg Med Chem Lett (2001) 11: 1839-1842 [PMID:11459643] |
ChEMBL | DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) | B | 7.41 | pKi | 39 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | Binding affinity towards estrogen receptor alpha by [3H]17-beta-estradiol displacement. | B | 5.21 | pIC50 | 6100 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 2327-2330 [PMID:15081034] |
ChEMBL | Binding Assay: The binding affinity and selectivity of candidate molecules yielded from database screening were determined by a fluorescent polarization competitive binding assay using purified baculovirus-expressed human ER beta or ER alpha and a fluorescent estrogen ligand EL Red (PanVera Corp.). | B | 5.33 | pIC50 | 4680 | nM | IC50 | US-8552057-B2. Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases (2013) |
ChEMBL | Binding affinity for human Estrogen receptor Alpha | B | 5.33 | pIC50 | 4660 | nM | IC50 | J Med Chem (2005) 48: 3463-3466 [PMID:15887952] |
ChEMBL | Binding affinity for human Estrogen receptor Alpha | B | 5.33 | pIC50 | 4660 | nM | IC50 | J Med Chem (2005) 48: 3463-3466 [PMID:15887952] |
ChEMBL | Binding affinity to human ERalpha | B | 5.67 | pIC50 | 2150 | nM | IC50 | J Med Chem (2007) 50: 4471-4481 [PMID:17696335] |
ChEMBL | Displacement of [3H]estrone from ER alpha | B | 5.7 | pIC50 | 1973 | nM | IC50 | J Med Chem (2006) 49: 2440-2455 [PMID:16610787] |
ChEMBL | Inhibition of binding of 17 beta-estradiol to human Estrogen receptor alpha | B | 5.89 | pIC50 | 1300 | nM | IC50 | Bioorg Med Chem Lett (2001) 11: 1839-1842 [PMID:11459643] |
ChEMBL | Displacement of [3H]E2 from human recombinant ERalpha LBD by SPA | B | 5.94 | pIC50 | 1145 | nM | IC50 | J Med Chem (2006) 49: 7357-7365 [PMID:17149865] |
ChEMBL | Displacement of [3H]17beta-estradiol from recombinant human ERalpha | B | 6.24 | pIC50 | 580 | nM | IC50 | Bioorg Med Chem (2007) 15: 5828-5836 [PMID:17574424] |
ChEMBL | Binding affinity for human Estrogen receptor alpha | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 4520-4525 [PMID:16098741] |
ChEMBL | Binding affinity for human Estrogen receptor alpha | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 4925-4929 [PMID:15341953] |
ChEMBL | Inhibitory concentration against human ER alpha expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand | B | 6.4 | pIC50 | 395 | nM | IC50 | J Med Chem (2004) 47: 5021-5040 [PMID:15456246] |
ChEMBL | Inhibition of [3H]17-beta-estradiol binding to human estrogen receptor alpha expressed in Escherichia coli | B | 6.4 | pIC50 | 395 | nM | IC50 | J Med Chem (2005) 48: 3953-3979 [PMID:15943471] |
ChEMBL | Inhibition of human ERalpha by radioligand binding assay | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 902-906 [PMID:17188490] |
ChEMBL | Binding affinity towards human estrogen receptor alpha(ERalpha) | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 2399-2403 [PMID:12824043] |
ChEMBL | Displacement of [3H]estradiol from human recombinant ERalpha | B | 6.52 | pIC50 | 300 | nM | IC50 | J Nat Prod (2002) 65: 1749-1753 [PMID:12502307] |
ChEMBL | DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) | B | 6.87 | pIC50 | 135 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | Binding affinity against human estrogen receptor alpha in competitive binding assay | B | 7.04 | pIC50 | 92 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 1417-1421 [PMID:15006374] |
ChEMBL | Displacement of [3H]17beta-estradiol from recombinant human ERalpha expressed in 293T cells | B | 7.53 | pIC50 | 29.4 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 5562-5566 [PMID:16219463] |
ChEMBL | Inhibition of human LBD of of ERalpha | B | 8.01 | pIC50 | 9.7 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 118-122 [PMID:17049855] |
ChEMBL | Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor alpha. | B | 5.41 | pEC50 | 3920 | nM | EC50 | J Med Chem (2002) 45: 1399-1401 [PMID:11906280] |
ChEMBL | Ability to activate estrogen receptor 1-mediated transcription. | F | 6.02 | pEC50 | 950 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 2327-2330 [PMID:15081034] |
ChEMBL | Agonist activity at human ERalpha expressed in yeast AH109 by yeast two hybrid assay | F | 6.09 | pEC50 | 810 | nM | EC50 | Bioorg Med Chem (2007) 15: 5828-5836 [PMID:17574424] |
ChEMBL | Agonist activity at human ER-alpha transfected in HEK293 cells after 48 hrs by luciferase reporter gene assay | B | 6.3 | pEC50 | 501.19 | nM | EC50 | Medchemcomm (2013) 4: 1439-1442 |
ChEMBL | Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha. | B | 7.32 | pEC50 | 48 | nM | EC50 | J Med Chem (2002) 45: 1399-1401 [PMID:11906280] |
ChEMBL | Transcriptional potency (EC50) at Human estrogen receptor alpha | B | 7.7 | pEC50 | 20 | nM | EC50 | J Med Chem (2001) 44: 4230-4251 [PMID:11708925] |
Estrogen receptor-β/Estrogen receptor beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL242] [GtoPdb: 621] [UniProtKB: Q92731] | ||||||||
ChEMBL | Inhibition of binding of 17 beta-estradiol to human Estrogen receptor beta | B | 7.62 | pKi | 24 | nM | Ki | Bioorg Med Chem Lett (2001) 11: 1839-1842 [PMID:11459643] |
GtoPdb | - | - | 8.2 | pKi | - | - | - | Endocrinology (1997) 138: 863-70 [PMID:9048584] |
ChEMBL | DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol) | B | 9.23 | pKi | 0.59 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | Binding affinity to human ERbeta | B | 4.34 | pIC50 | 45900 | nM | IC50 | J Med Chem (2007) 50: 4471-4481 [PMID:17696335] |
ChEMBL | Inhibition of human LBD of ERbeta | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 118-122 [PMID:17049855] |
ChEMBL | Binding affinity towards estrogen receptor beta by [3H]17-beta-estradiol displacement. | B | 6.41 | pIC50 | 390 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 2327-2330 [PMID:15081034] |
ChEMBL | Binding affinity for human Estrogen receptor beta | B | 7.01 | pIC50 | 98.7 | nM | IC50 | J Med Chem (2005) 48: 3463-3466 [PMID:15887952] |
ChEMBL | Binding Assay: The binding affinity and selectivity of candidate molecules yielded from database screening were determined by a fluorescent polarization competitive binding assay using purified baculovirus-expressed human ER beta or ER alpha and a fluorescent estrogen ligand EL Red (PanVera Corp.). | B | 7.01 | pIC50 | 98.7 | nM | IC50 | US-8552057-B2. Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases (2013) |
ChEMBL | Binding affinity for human Estrogen receptor beta | B | 7.01 | pIC50 | 98.7 | nM | IC50 | J Med Chem (2005) 48: 3463-3466 [PMID:15887952] |
ChEMBL | Inhibition of binding of 17 beta-estradiol to human Estrogen receptor beta | B | 7.08 | pIC50 | 83 | nM | IC50 | Bioorg Med Chem Lett (2001) 11: 1839-1842 [PMID:11459643] |
ChEMBL | Displacement of [3H]estrone from ER beta | B | 7.21 | pIC50 | 61 | nM | IC50 | J Med Chem (2006) 49: 2440-2455 [PMID:16610787] |
ChEMBL | Displacement of [3H]E2 from human recombinant ERbeta LBD by SPA | B | 7.6 | pIC50 | 25 | nM | IC50 | J Med Chem (2006) 49: 7357-7365 [PMID:17149865] |
ChEMBL | Displacement of [3H]estradiol from human recombinant ERbeta | B | 7.74 | pIC50 | 18 | nM | IC50 | J Nat Prod (2002) 65: 1749-1753 [PMID:12502307] |
ChEMBL | Binding affinity towards human estrogen receptor beta (ERbeta) | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 2399-2403 [PMID:12824043] |
ChEMBL | Binding affinity for human Estrogen receptor beta | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 4520-4525 [PMID:16098741] |
ChEMBL | Binding affinity for human Estrogen receptor beta | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 4925-4929 [PMID:15341953] |
ChEMBL | Inhibitory concentration against human ER beta expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2004) 47: 5021-5040 [PMID:15456246] |
ChEMBL | Inhibition of human ERbeta by radioligand binding assay | B | 8.01 | pIC50 | 9.7 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 902-906 [PMID:17188490] |
ChEMBL | Inhibition of [3H]17-beta-estradiol binding to human estrogen receptor beta expressed in Escherichia coli | B | 8.01 | pIC50 | 9.7 | nM | IC50 | J Med Chem (2005) 48: 3953-3979 [PMID:15943471] |
ChEMBL | Displacement of [3H]17beta-estradiol from recombinant human ERbeta | B | 8.17 | pIC50 | 6.8 | nM | IC50 | Bioorg Med Chem (2007) 15: 5828-5836 [PMID:17574424] |
ChEMBL | Binding affinity against human estrogen receptor beta (ER beta) in competitive binding assay | B | 8.4 | pIC50 | 4 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 1417-1421 [PMID:15006374] |
ChEMBL | DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol) | B | 8.54 | pIC50 | 2.88 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | Displacement of [3H]17beta-estradiol from recombinant human ERbeta expressed in 293T cells | B | 8.89 | pIC50 | 1.3 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 5562-5566 [PMID:16219463] |
ChEMBL | Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay at 10 uM | F | 6.02 | pEC50 | 956 | nM | EC50 | J Med Chem (2006) 49: 2440-2455 [PMID:16610787] |
ChEMBL | Ability to activate estrogen receptor 2-mediated transcription. | F | 6.7 | pEC50 | 200 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 2327-2330 [PMID:15081034] |
ChEMBL | Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor beta. | B | 6.7 | pEC50 | 200 | nM | EC50 | J Med Chem (2002) 45: 1399-1401 [PMID:11906280] |
ChEMBL | Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay | F | 7.14 | pEC50 | 73 | nM | EC50 | J Med Chem (2006) 49: 2440-2455 [PMID:16610787] |
ChEMBL | Agonist activity at human ERbeta expressed in yeast AH109 by yeast two hybrid assay | F | 7.55 | pEC50 | 28 | nM | EC50 | Bioorg Med Chem (2007) 15: 5828-5836 [PMID:17574424] |
ChEMBL | Agonist activity at human ER-beta transfected in HEK293 cells after 48 hrs by luciferase reporter gene assay | B | 7.7 | pEC50 | 19.95 | nM | EC50 | Medchemcomm (2013) 4: 1439-1442 |
ChEMBL | Transcriptional potency (EC50) at Human estrogen receptor Beta | B | 8.22 | pEC50 | 6 | nM | EC50 | J Med Chem (2001) 44: 4230-4251 [PMID:11708925] |
ChEMBL | Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta. | B | 8.39 | pEC50 | 4.1 | nM | EC50 | J Med Chem (2002) 45: 1399-1401 [PMID:11906280] |
ChEMBL | Estrogenic activity at ERbeta (unknown origin) expressed in human MDA-MB-231/beta41 cells after 18 hrs by renilla luciferase reporter gene assay | B | 8.62 | pEC50 | 2.4 | nM | EC50 | J Nat Prod (2018) 81: 966-975 [PMID:29641206] |
ChEMBL | Agonist activity in transcriptional activation assay in SH-SY5Y neuroblastoma cells expressing Estrogen receptor beta | F | 8.77 | pEC50 | 1.7 | nM | EC50 | J Med Chem (2002) 45: 1399-1401 [PMID:11906280] |
Estrogen-related receptor-α/Estrogen-related receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3429] [GtoPdb: 622] [UniProtKB: P11474] | ||||||||
ChEMBL | Inhibition of human ERalpha | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 4053-4056 [PMID:17482813] |
Estrogen-related receptor-β/Estrogen-related receptor beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3751] [GtoPdb: 623] [UniProtKB: O95718] | ||||||||
ChEMBL | Inhibition of human ERbeta | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 4053-4056 [PMID:17482813] |
Fatty acid synthase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4512] [UniProtKB: Q965D7] | ||||||||
ChEMBL | Inhibition of FabZ | B | 5.15 | pIC50 | 7000 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
Glucose transporter 1/Glucose transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2535] [GtoPdb: 875] [UniProtKB: P11166] | ||||||||
ChEMBL | Competitive inhibition of glucose displaceable binding of [4-3H]cytochalasin B to GLUT1 in human erythrocyte membranes after 10 mins by double reciprocal plot analysis | B | 5.15 | pKi | 7000 | nM | Ki | Medchemcomm (2016) 7: 1716-1729 [PMID:28042452] |
ChEMBL | Competitive inhibition of GLUT1 (unknown origin) expressed in CHO cells assessed as reduction in 2-[1,2-3H]deoxy-D-glucose uptake measured for 30 secs by double reciprocal plot analysis | B | 5.15 | pKi | 7000 | nM | Ki | Medchemcomm (2016) 7: 1716-1729 [PMID:28042452] |
ChEMBL | Competitive inhibition of GLUT1 in human HL60 cells assessed as reduction in 2-[1,2-3H]deoxy-D-glucose uptake measured for 30 secs by double reciprocal plot analysis | B | 5.15 | pKi | 7000 | nM | Ki | Medchemcomm (2016) 7: 1716-1729 [PMID:28042452] |
Human immunodeficiency virus type 1 integrase in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3471] [UniProtKB: Q7ZJM1] | ||||||||
ChEMBL | Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis | B | 4.7 | pIC50 | >20000 | nM | IC50 | Bioorg Med Chem (2014) 22: 3146-3158 [PMID:24794743] |
ChEMBL | Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis | B | 4.7 | pIC50 | >20000 | nM | IC50 | Bioorg Med Chem (2014) 22: 3146-3158 [PMID:24794743] |
ChEMBL | Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem (2014) 22: 3146-3158 [PMID:24794743] |
Liver X receptor-α/LXR-alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2808] [GtoPdb: 602] [UniProtKB: Q13133] | ||||||||
ChEMBL | Antagonist activity at human recombinant LXRalpha expressed in HEK293 cells by luciferase reporter gene assay | F | 4.51 | pIC50 | 31000 | nM | IC50 | Bioorg Med Chem (2008) 16: 4272-4285 [PMID:18343126] |
Liver X receptor-β/LXR-beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4093] [GtoPdb: 601] [UniProtKB: P55055] | ||||||||
ChEMBL | Antagonist activity at human recombinant LXRbeta expressed in HEK293 cells by luciferase reporter gene assay | F | 4.66 | pIC50 | 22000 | nM | IC50 | Bioorg Med Chem (2008) 16: 4272-4285 [PMID:18343126] |
maltase-glucoamylase/Maltase-glucoamylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2074] [GtoPdb: 2627] [UniProtKB: O43451] | ||||||||
ChEMBL | Inhibition kinetics of yeast alpha-glucosidase by genistein at a concentration of 10.2 uM | B | 4.98 | pKi | 10400 | nM | Ki | Bioorg Med Chem Lett (2004) 14: 2947-2950 [PMID:15125965] |
ChEMBL | Inhibition of yeast alpha-glucosidase by genistein | B | 4.98 | pIC50 | 10400 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 2947-2950 [PMID:15125965] |
ChEMBL | Inhibition of yeast alpha-glucosidase after addition of D-glucose | B | 5.58 | pIC50 | 2610 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 2947-2950 [PMID:15125965] |
Monoamine oxidase A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1951] [GtoPdb: 2489] [UniProtKB: P21397] | ||||||||
ChEMBL | Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI insect cells assessed as decrease in arbitrary light units preincubated for 40 mins followed by addition of luciferin derivative substrate measured after 2 hrs by MAO-Glow assay | B | 5.01 | pIC50 | 9700 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4714-4719 [PMID:27575476] |
ChEMBL | Inhibition of human recombinant MAOA using kynuramine as substrate preincubated for 30 mins followed by substrate addition | B | 5.41 | pIC50 | 3900 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 584-588 [PMID:29395970] |
ChEMBL | Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI insect cells preincubated for 10 mins followed by addition of kynuramine as substrate | B | 5.41 | pIC50 | 3900 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4714-4719 [PMID:27575476] |
ChEMBL | DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) | B | 5.6 | pIC50 | 2520 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Monoamine oxidase A in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3358] [UniProtKB: P21396] | ||||||||
ChEMBL | Inhibition of rat brain mitochondrial MAO-A preincubated for 15 mins followed by addition of serotonin as substrate measured after 90 mins | B | 4.4 | pIC50 | 40000 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4714-4719 [PMID:27575476] |
Monoamine oxidase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2039] [GtoPdb: 2490] [UniProtKB: P27338] | ||||||||
ChEMBL | Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells assessed as decrease in arbitrary light units preincubated for 40 mins followed by addition of luciferin derivative substrate measured after 2 hrs by MAO-Glow assay | B | 5.17 | pIC50 | 6800 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4714-4719 [PMID:27575476] |
ChEMBL | Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells preincubated for 10 mins followed by addition of benzylamine as substrate | B | 5.39 | pIC50 | 4100 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4714-4719 [PMID:27575476] |
Neuraminidase in Influenza A virus (A/Puerto Rico/8/1934(H1N1)) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2051] [UniProtKB: P03468] | ||||||||
ChEMBL | Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay | B | 1.32 | pIC50 | 1.32 | - | logIC50 | Eur J Med Chem (2010) 45: 1724-1730 [PMID:20116898] |
Neuraminidase in Influenza A virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6135] [UniProtKB: B4URF0] | ||||||||
ChEMBL | Inhibition of Influenza A Jiangsu/10/2003 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay | B | 4.08 | pIC50 | 83300 | nM | IC50 | Bioorg Med Chem (2008) 16: 7141-7147 [PMID:18640042] |
ChEMBL | Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay | B | 4.11 | pIC50 | 77100 | nM | IC50 | Bioorg Med Chem (2008) 16: 7141-7147 [PMID:18640042] |
Ornithine decarboxylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1869] [GtoPdb: 1276] [UniProtKB: P11926] | ||||||||
ChEMBL | Inhibition of phorbol ester-induced ornithine decarboxylase in human MCF7 cells after 6 hrs | B | 4.59 | pIC50 | 26000 | nM | IC50 | J Nat Prod (1999) 62: 205-210 [PMID:10075742] |
Pancreatic triacylglycerol lipase in Pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1687677] [UniProtKB: P00591] | ||||||||
ChEMBL | Inhibition of porcine pancreatic lipase pre-incubated for 15 mins before p-nitrophenylbutyrate substrate addition by microplate reader based method | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 3455-3457 [PMID:26227773] |
ABCB1/P-glycoprotein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4302] [GtoPdb: 768] [UniProtKB: P08183] | ||||||||
ChEMBL | Binding affinity to ABCB1 nucleotide binding domain 2 | B | 4.58 | pKd | 26302.68 | nM | Kd | Eur J Med Chem (2011) 46: 4078-4088 [PMID:21723648] |
Plasmodium berghei (target type: ORGANISM) [ChEMBL: CHEMBL612653] | ||||||||
ChEMBL | Antimalarial activity against liver stages of Plasmodium berghei | F | 4.7 | pIC50 | 20000 | nM | IC50 | J Med Chem (2012) 55: 995-1012 [PMID:22122518] |
ChEMBL | Antiplasmodial activity against liver sporozoite stage of Plasmodium berghei ANKA expressing GFP infected in human HuH7 cells assessed as inhibition of parasite development after 24 hrs by qRT-PCR analysis | F | 4.7 | pIC50 | 20000 | nM | IC50 | Eur J Med Chem (2013) 69: 872-880 [PMID:24125849] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54 | F | 4.42 | pIC50 | 38200 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
proteasome 20S subunit beta 5/Proteasome Macropain subunit MB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4662] [GtoPdb: 2406] [UniProtKB: P28074] | ||||||||
ChEMBL | Inhibition of chymotrypsin-like activity of human 26S proteasome extracted from human LNCap cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 60 mins by fluorescence based method | B | 4.19 | pIC50 | 65000 | nM | IC50 | Eur J Med Chem (2019) 167: 291-311 [PMID:30776692] |
ChEMBL | Inhibition of chymotrypsin-like activity of purified human erythrocyte 20S proteasome assessed as decrease in AMC hydrolysis using Suc-LLVY-AMC as substrate preincubated for 10 mins and measured by fluorescence based method | B | 5.03 | pIC50 | 9260 | nM | IC50 | Eur J Med Chem (2019) 167: 291-311 [PMID:30776692] |
protein kinase C alpha/Protein kinase C alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL299] [GtoPdb: 1482] [UniProtKB: P17252] | ||||||||
ChEMBL | Inhibition of Protein kinase C alpha | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (1999) 42: 1018-1026 [PMID:10090785] |
Protein kinase Pfmrk in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4090] [UniProtKB: P90584] | ||||||||
ChEMBL | Inhibition of Plasmodium falciparum cyclin-dependent kinase | B | 4.03 | pIC50 | 93000 | nM | IC50 | J Med Chem (2004) 47: 5418-5426 [PMID:15481979] |
AKT serine/threonine kinase 1/Serine/threonine-protein kinase AKT in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4282] [GtoPdb: 1479] [UniProtKB: P31749] | ||||||||
ChEMBL | Inhibition of Akt by fluorescence polarization assay | B | 4.15 | pIC50 | >70000 | nM | IC50 | J Med Chem (2006) 49: 3800-3808 [PMID:16789737] |
5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL224] [GtoPdb: 6] [UniProtKB: P28223] | ||||||||
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | B | 5.52 | pKi | 2991 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | B | 4.98 | pIC50 | 10469 | nM | IC50 | DrugMatrix in vitro pharmacology data |
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 5.11 | pKi | 7806 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 4.83 | pIC50 | 14910 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Sialidase in Clostridium perfringens (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5189] [UniProtKB: P10481] | ||||||||
ChEMBL | Inhibition of Clostridium perfringens neuraminidase using 4-methylumbelliferyl-alpha-D-N-acetylneuraminic acid sodium salt hydrate as substrate by fluorimetry | B | 4.92 | pIC50 | 12050 | nM | IC50 | Bioorg Med Chem (2013) 21: 6398-6404 [PMID:24054487] |
signal transducer and activator of transcription 3/Signal transducer and activator of transcription 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4026] [GtoPdb: 2994] [UniProtKB: P40763] | ||||||||
ChEMBL | Inhibition of IL-6-Induced STAT3 activation (unknown origin) expressed in human HepG2 cells expressing pSTAT3-luciferase pre-incubated for 1 hr before IL-6 stimulation for 6 hrs by luciferase reporter gene assay | B | 4.61 | pIC50 | 24800 | nM | IC50 | J Nat Prod (2017) 80: 3103-3111 [PMID:29140705] |
Glucose transporter 4/Solute carrier family 2, facilitated glucose transporter member 4 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1250410] [GtoPdb: 878] [UniProtKB: P14142] | ||||||||
ChEMBL | Inhibition of GLUT4 in mouse 3T3L1 cells assessed as reduction in insulin-stimulated 2-deoxy-D-[14C]glucose uptake | B | 4.7 | pIC50 | 20000 | nM | IC50 | Medchemcomm (2016) 7: 1716-1729 [PMID:28042452] |
Testis-specific androgen-binding protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3305] [UniProtKB: P04278] | ||||||||
ChEMBL | Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin | B | 4.4 | pKd | 39810.72 | nM | Kd | J Med Chem (2008) 51: 2047-2056 [PMID:18330978] |
CYP5A1/Thromboxane-A synthase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1835] [GtoPdb: 1353] [UniProtKB: P24557] | ||||||||
ChEMBL | DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) | B | 5.11 | pIC50 | 7720 | nM | IC50 | DrugMatrix in vitro pharmacology data |
transthyretin/Transthyretin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3194] [GtoPdb: 2851] [UniProtKB: P02766] | ||||||||
ChEMBL | Inhibition of transthyretin V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of sodium acetate-mediated aggregation preincubated for 30 mins followed by sodium acetate addition measured after 96 hrs by thioflavin T assay | B | 5.11 | pIC50 | 7800 | nM | IC50 | J Med Chem (2014) 57: 1090-1096 [PMID:24422526] |
ABL proto-oncogene 1, non-receptor tyrosine kinase/Tyrosine-protein kinase ABL in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1862] [GtoPdb: 1923] [UniProtKB: P00519] | ||||||||
ChEMBL | In vitro inhibition of the v-abl tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate | B | 5 | pIC50 | 10000 | nM | IC50 | J Med Chem (1995) 38: 2441-2448 [PMID:7608909] |
BMX non-receptor tyrosine kinase/Tyrosine-protein kinase BMX in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3834] [GtoPdb: 1942] [UniProtKB: P51813] | ||||||||
ChEMBL | Inhibition of Bmx (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay | B | 4.17 | pIC50 | 67990 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 4659-4663 [PMID:25205190] |
FYN proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase FYN in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1841] [GtoPdb: 2026] [UniProtKB: P06241] | ||||||||
ChEMBL | Inhibition of Fyn (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay | B | 4.24 | pIC50 | 58180 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 4659-4663 [PMID:25205190] |
SRC proto-oncogene, non-receptor tyrosine kinase/Tyrosine-protein kinase SRC in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL267] [GtoPdb: 2206] [UniProtKB: P12931] | ||||||||
ChEMBL | Inhibition of Src (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 4659-4663 [PMID:25205190] |
ChEMBL | In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate | B | 4.12 | pIC50 | 75000 | nM | IC50 | J Med Chem (1995) 38: 2441-2448 [PMID:7608909] |
ChEMBL | Inhibition of p60 c-Src tyrosine kinase | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (1999) 42: 1018-1026 [PMID:10090785] |
spleen associated tyrosine kinase/Tyrosine-protein kinase SYK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2599] [GtoPdb: 2230] [UniProtKB: P43405] | ||||||||
ChEMBL | Inhibition of recombinant Syk | B | 4.41 | pIC50 | 39000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 1944-1949 [PMID:19254842] |
Voltage-dependent L-type calcium channel subunit alpha-1C in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2366456] [UniProtKB: O35505] | ||||||||
ChEMBL | Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes | F | 4.7 | pIC50 | 20000 | nM | IC50 | J Appl Toxicol (2012) 32: 858-866 [PMID:22761000] |
Cav1.2/Voltage-gated L-type calcium channel alpha-1C subunit in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3762] [GtoPdb: 529] [UniProtKB: P22002] | ||||||||
ChEMBL | Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in rat Artery myocytes | F | 4.24 | pIC50 | 57500 | nM | IC50 | IC50 data for the L-type calcium channel extracted from a set of literature articles |
ChEMBL | Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes | F | 4.96 | pIC50 | 11000 | nM | IC50 | J Appl Toxicol (2012) 32: 858-866 [PMID:22761000] |
ChEMBL | Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in rat ventricular myocytes | F | 4.96 | pIC50 | 11000 | nM | IC50 | IC50 data for the L-type calcium channel extracted from a set of literature articles |
Xanthine dehydrogenase in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3649] [UniProtKB: P80457] | ||||||||
ChEMBL | Inhibition of bovine milk xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate preincubated for 3 hrs followed by substrate addition measured after 1 min by UV spectrophotometric assay | B | 5.76 | pIC50 | 1730 | nM | IC50 | Eur J Med Chem (2017) 135: 491-516 [PMID:28478180] |
TAS2R14 in Human [GtoPdb: 668] [UniProtKB: Q9NYV8] | ||||||||
GtoPdb | - | - | 4.19 | pEC50 | 63900 | nM | EC50 | Biochim Biophys Acta Gen Subj (2018) 1862: 2162-2173 [PMID:30009876] |
TAS2R39 in Human [GtoPdb: 675] [UniProtKB: P59534] | ||||||||
GtoPdb | - | - | 4.31 | pEC50 | 49400 | nM | EC50 | J Agric Food Chem (2011) 59: 11764-71 [PMID:21942422] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]